Rechercher un essai clinique
Autre(s) option(s) de recherche
10 Résultat(s)
Essai en cours de recrutement = 
; Essai en cours = 
; Financé par un membre IRDiRC = 
; Membre d'un ERN = 
Essai(s) clinique(s) national(aux)
ROYAUME-UNI
Strathclyde
GLASGOW
An Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon for the Treatment of Children With Congenital Hyperinsulinism-GB
NHS Greater Glasgow and Clyde Corporate HQ
Greater Glasgow and Clyde NHS Board
ETATS-UNIS
Pennsylvania
PHILADELPHIA
Role of GLP-1 In Congenital Hyperinsulinism: Effect of Exendin-(9-39) on Glucose Requirements To Maintain Euglycemia (Phase 1/2) - US
The Children's Hospital of Philadelphia
Center of Congenital Hyperinsulinism
AUTRICHE
WIEN
ADDRESS: NOT PROVIDED - AT
A Randomised, Controlled, Open-Label Parallel Arm Study of Safety, PK and Ammonia Control of RAVICTI® (Glycerol Phenylbutyrate) Oral Liquid and Sodium Phenylbutyrate in Phenylbutyrate Treatment Naïve Patients With Urea Cycle Disorders (Phase 4) - AT
Institution: Information not provided - AT
ESPAGNE
Andalucía
MÁLAGA
A Randomised, Controlled, Open-Label Parallel Arm Study of Safety, PK and Ammonia Control of RAVICTI® (Glycerol Phenylbutyrate) Oral Liquid and Sodium Phenylbutyrate in Phenylbutyrate Treatment Naïve Patients With Urea Cycle Disorders (Phase IV) - ES
Hospital Regional Universitario de Málaga - Hospital Materno-Infantil
Unidad de Gastroenterología y Nutrición Infantil
ESPAGNE
Cataluña
BARCELONA
A Randomised, Controlled, Open-Label Parallel Arm Study of Safety, PK and Ammonia Control of RAVICTI® (Glycerol Phenylbutyrate) Oral Liquid and Sodium Phenylbutyrate in Phenylbutyrate Treatment Naïve Patients With Urea Cycle Disorders (Phase IV) - ES
Hospital Universitari Vall d'Hebron
ESPAGNE
Galicia
SANTIAGO DE COMPOSTELA
A Randomised, Controlled, Open-Label Parallel Arm Study of Safety, PK and Ammonia Control of RAVICTI® (Glycerol Phenylbutyrate) Oral Liquid and Sodium Phenylbutyrate in Phenylbutyrate Treatment Naïve Patients With Urea Cycle Disorders (Phase IV) - ES
Hospital Clínico Universitario de Santiago
ESPAGNE
Madrid
ADDRESS: NOT PROVIDED - ES
UNLOCKED: A Phase 2, Open-label Study to Evaluate the Efficacy and Safety of KB195 in Subjects with a Urea Cycle Disorder with Inadequate Control on Standard of Care - ES
Institution: Information not provided - ES
ESPAGNE
País Vasco
BARAKALDO
A Randomised, Controlled, Open-Label Parallel Arm Study of Safety, PK and Ammonia Control of RAVICTI® (Glycerol Phenylbutyrate) Oral Liquid and Sodium Phenylbutyrate in Phenylbutyrate Treatment Naïve Patients With Urea Cycle Disorders (Phase IV) - ES
Hospital Universitario Cruces
Unidad de Trastornos Congénitos del Metabolismo
Essai(s) clinique(s) multinational(aux)
DANEMARK
Sjælland
GLOSTRUP
An Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon for the Treatment of Children With Congenital Hyperinsulinism
Zealand Pharma A/S
ETATS-UNIS
Illinois
LAKE FOREST